Compositions and methods regarding guanidinium functionalized polycarbonates that provide potent antimicrobial activity against multidrug resistant (MDR) bacteria, including Klebsiella pneumoniae (K. pneumoniae) are provided. According to an embodiment, an antimicrobial guanidinium-functionalized polymer is provided that comprises a hydrophobic molecular backbone with cationic guanidinium moieties respectively bound to the hydrophobic molecular backbone via butyl spacer groups. The antimicrobial guanidinium-functionalized polymer self-assembles into a micelle structure with hydrophobic residuals of the antimicrobial guanidinium-functionalized polymer buried inside the micelle structure and the cationic guanidinium moieties exposed on an external surface of the micelle structure to target pathogens.

Compositions and methods regarding guanidinium functionalized polycarbonates that provide potent antimicrobial activity against multidrug resistant (MDR) bacteria, including Klebsiella pneumoniae (K. pneumoniae) are provided. According to an embodiment, an antimicrobial guanidinium-functionalized polymer is provided that comprises a hydrophobic molecular backbone with cationic guanidinium moieties respectively bound to the hydrophobic molecular backbone via butyl spacer groups. The antimicrobial guanidinium-functionalized polymer self-assembles into a micelle structure with hydrophobic residuals of the antimicrobial guanidinium-functionalized polymer buried inside the micelle structure and the cationic guanidinium moieties exposed on an external surface of the micelle structure to target pathogens.

Compositions and methods regarding guanidinium functionalized polycarbonates that provide potent antimicrobial activity against multidrug resistant (MDR) bacteria, including Klebsiella pneumoniae (K. pneumoniae) are provided. According to an embodiment, an antimicrobial guanidinium-functionalized polymer is provided that comprises a hydrophobic molecular backbone with cationic guanidinium moieties respectively bound to the hydrophobic molecular backbone via butyl spacer groups. The antimicrobial guanidinium-functionalized polymer self-assembles into a micelle structure with hydrophobic residuals of the antimicrobial guanidinium-functionalized polymer buried inside the micelle structure and the cationic guanidinium moieties exposed on an external surface of the micelle structure to target pathogens.

Compositions and methods regarding guanidinium functionalized polycarbonates that provide potent antimicrobial activity against multidrug resistant (MDR) bacteria, including Klebsiella pneumoniae (K. pneumoniae) are provided. According to an embodiment, an antimicrobial guanidinium-functionalized polymer is provided that comprises a hydrophobic molecular backbone with cationic guanidinium moieties respectively bound to the hydrophobic molecular backbone via butyl spacer groups. The antimicrobial guanidinium-functionalized polymer self-assembles into a micelle structure with hydrophobic residuals of the antimicrobial guanidinium-functionalized polymer buried inside the micelle structure and the cationic guanidinium moieties exposed on an external surface of the micelle structure to target pathogens.

The present invention relates to a process for producing (cyclo)aliphatic polycarbonate polyols comprising the steps of a) reaction of at least one (cyclo)aliphatic polyol and at least one alkyl carbonate in the presence of at least one basic catalyst and b) neutralization by addition of at least one organic sulfonic acid having a molecular weight of 250 to 1000 g/mol and at least one branched or unbranched alkyl substitution having at least four carbon atoms,
wherein step b) is performed after step a).

The present invention relates to a process for producing (cyclo)aliphatic polycarbonate polyols comprising the steps of a) reaction of at least one (cyclo)aliphatic polyol and at least one alkyl carbonate in the presence of at least one basic catalyst and b) neutralization by addition of at least one organic sulfonic acid having a molecular weight of 250 to 1000 g/mol and at least one branched or unbranched alkyl substitution having at least four carbon atoms,
wherein step b) is performed after step a).

A method for preparing a modified polycarbonate comprising i) providing a polycarbonate prepared by the melt transesterification of a bisphenol and a diaryl carbonate preferably having a Fries branching level of from 750 to 2000 ppm, ii) combining said polycarbonate and from 0.10-0.75 wt. %, based on the amount of polycarbonate, of a modifier, iii) reacting said modifier and said polycarbonate in molten state at a temperature of from 250-300 C. and a reaction time of at least 30 seconds so as to form the modified polycarbonate, wherein said modifier is a styrene-(meth)acrylate copolymer containing glycidyl groups and having i) from 250 to 500 gram epoxy groups per mol and ii) a weight average molecular weight of from 3000 to 8500 g/mol, and wherein said modified polycarbonate has a transmittance of at least 85% and a haze of at most 5% as determined in accordance with ASTM D1003-13 on an injection moulded sheet having a thickness of 3 mm.

A method for preparing a modified polycarbonate comprising i) providing a polycarbonate prepared by the melt transesterification of a bisphenol and a diaryl carbonate preferably having a Fries branching level of from 750 to 2000 ppm, ii) combining said polycarbonate and from 0.10-0.75 wt. %, based on the amount of polycarbonate, of a modifier, iii) reacting said modifier and said polycarbonate in molten state at a temperature of from 250-300 C. and a reaction time of at least 30 seconds so as to form the modified polycarbonate, wherein said modifier is a styrene-(meth)acrylate copolymer containing glycidyl groups and having i) from 250 to 500 gram epoxy groups per mol and ii) a weight average molecular weight of from 3000 to 8500 g/mol, and wherein said modified polycarbonate has a transmittance of at least 85% and a haze of at most 5% as determined in accordance with ASTM D1003-13 on an injection moulded sheet having a thickness of 3 mm.

This invention relates to compositions, and related methods, of synthetic nanocarriers that comprise immunomodulatory agents and antigens that are differentially released from the synthetic nanocarriers.

This invention relates to compositions, and related methods, of synthetic nanocarriers that comprise immunomodulatory agents and antigens that are differentially released from the synthetic nanocarriers.